Effect of sustained use of platelet aggregation inhibitors on post-endoscopic sphincterotomy bleeding

Digestive Endoscopy

Volumn 26, Issue 6, 2014, Pages 737-744

  Lee, Min Geun ^a,d   Kim, Jaihwan ^a,c   Lee, Sang Hyub ^a,b   Lee, Ban Seok ^a,b   Lee, Seung June ^a,c   Lee, Yoon Suk ^a,c   Cha, Byung Hyo ^e   Hwang, Jin Hyeok ^a,c   Ryu, Ji Kon ^a,b   Kim, Yong Tae ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Hanmaeum Hospital   (South Korea)

^e Halla General Hospital   (South Korea)

Author keywords

acetylsalicylic acid; endoscopic retrograde cholangiopancreatography (ERCP); endoscopic sphincterotomy (ES); gastrointestinal hemorrhage; platelet aggregation inhibitor

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; SARPOGRELATE; TICLOPIDINE;

ADULT; ARTICLE; DISEASE SEVERITY; DRUG EFFECT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; RISK FACTOR; SPHINCTEROTOME; ADVERSE EFFECTS; AGED; MIDDLE AGED; RETROSPECTIVE STUDY; SOUTH KOREA;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SPHINCTEROTOMY, ENDOSCOPIC;

EID: 84916602257     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/den.12271     Document Type: Article

References (23)

1. Kawai K, Akasaka Y, Murakami K, Tada M, Kohli Y, Nakajima M,. Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest. Endosc. 1974; 20: 148-151.
2. Cotton P, Chung S, Davis WZ, Gibson R, Ransohoff D, Strasberg S,. Issues in cholecystectomy and management of duct stones. Am. J. Gastroenterol. 1994; 89: S169-176.
3. Strasberg SM, Soper NJ,. Management of choledocholithiasis in the laparoscopic era. Gastroenterology 1995; 109: 320-322.
4. Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP,. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N. Engl. J. Med. 1989; 320: 82-87.
5. Riemann J, Lux G, Förster P, Altendorf A,. Long-term results after endoscopic papillotomy. Endoscopy 1983; 15: 165-168.
6. Nakajima H, Takami H, Yamagata K, Kariya K, Tamai Y, Nara H,. Aspirin effects on colonic mucosal bleeding. Dis. Colon Rectum 1997; 40: 1484-1488.
7. Fork FT, Lafolie P, Toth E, Lindgärde F,. Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers: A gastroscopic study. Scand. J. Gastroenterol. 2000; 35: 464-469.
8. Leung JWC, Chan FKL, Sung JJY, Chung S,. Endoscopic sphincterotomy-induced hemorrhage: A study of risk factors and the role of epinephrine injection. Gastrointest. Endosc. 1995; 42: 550-554.
9. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N. Engl. J. Med. 1996; 335: 909-919.
10. Nelson DB, Freeman ML,. Major hemorrhage from endoscopic sphincterotomy: Risk factor analysis. J. Clin. Gastroenterol. 1994; 19: 283-287.
11. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: A prospective multicenter study. Am. J. Gastroenterol. 2001; 96: 417-423.
12. Cotton PB, Garrow DA, Gallagher J, Romagnuolo J,. Risk factors for complications after ERCP: A multivariate analysis of 11,497 procedures over 12 years. Gastrointest. Endosc. 2009; 70: 80-88.
13. Freeman ML,. Understanding risk factors and avoiding complications with endoscopic retrograde cholangiopancreatography. Curr. Gastroenterol. Rep. 2003; 5: 145-153.
14. Hui CK, Lai KC, Yuen MF, Wong WM, Lam SK, Lai CL,. Does withholding aspirin for one week reduce the risk of post-sphincterotomy bleeding? Aliment. Pharmacol. Ther. 2002; 16: 929-936.
15. Boustière C, Veitch A, Vanbiervliet G, et al. Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy 2011; 43: 445-458.
16. Kim KO, Kim TN, Kim SB, Lee JY,. Characteristics of delayed hemorrhage after endoscopic sphincterotomy. J. Gastroenterol. Hepatol. 2010; 25: 532-538.
17. Cotton P, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest. Endosc. 1991; 37: 383-393.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 1987; 40: 373-383.
19. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest. Endosc. 2001; 54: 425-434.
20. Anderson MA, Ben-Menachem T, Gan SI, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest. Endosc. 2009; 70: 1060-1070.
21. Schafer AI,. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J. Clin. Pharmacol. 1995; 35: 209-219.
22. Komatsu T, Tamai Y, Takami H, Yamagata K, Fukuda S, Munakata A,. Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures. J. Gastroenterol. 2005; 40: 698-707.
23. Maree AO, Fitzgerald DJ,. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation 2007; 115: 2196-2207.